Modulatory effect of 1,25-dihydroxyvitamin D3 on IL1 β -induced RANKL, OPG, TNF α, and IL-6 expression in human rheumatoid synoviocyte MH7A

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Feng, Xiaoke ^a   Lv, Chengyin ^a   Wang, Fang ^a   Gan, Ke ^a,b   Zhang, Miaojia ^a   Tan, Wenfeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOTOXIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA; 1,25-DIHYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATION; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIOCYTE; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; OSTEOLYSIS; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANIMALS; ARTHRITIS, RHEUMATOID; BONE RESORPTION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

EID: 84890087335     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/160123     Document Type: Article

References (33)

1. Le G. B., Berthelot J. M., Maugars Y., Heymann D., Osteoclasts in RA: diverse origins and functions. Joint Bone Spine 2013 10.1016/j.jbspin.2013.04. 002
2. Takayanagi H., Osteoimmunology and the effects of the immune system on bone. Nature Reviews Rheumatology 2009 5 12 667 676 2-s2.0-75049085147 10.1038/nrrheum.2009.217
3. Pettit A. R., Ji H., von Stechow D., Müller R., Goldring S. R., Choi Y., Benoist C., Gravallese E. M., TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. The American Journal of Pathology 2001 159 5 1689 1699 2-s2.0-0035153246 (Pubitemid 33062512)
4. Choi Y., Arron J. R., Townsend M. J., Promising bone-related therapeutic targets for rheumatoid arthritis. Nature Reviews Rheumatology 2009 5 10 543 548 2-s2.0-70349964679 10.1038/nrrheum.2009.175
5. Christakos S., Dhawan P., Liu Y., Peng X., Porta A., New insights into the mechanisms of vitamin D action. Journal of Cellular Biochemistry 2003 88 4 695 705 2-s2.0-0037371241 10.1002/jcb.10423 (Pubitemid 36258819)
6. Onal M., Xiong J., Chen X., Thostenson J. D., Almeida M., Manolagas S. C., Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. The Journal of Biological Chemistry 2012 287 29851 29860
7. Fujii T., Kitaura H., Kimura K., Hakami Z. W., Takano-Yamamoto T., IL-4 inhibits TNF-alpha-mediated osteoclast formation by inhibition of RANKL expression in TNF-alpha-activated stromal cells and direct inhibition of TNF-alpha-activated osteoclast precursors via a T-cell-independent mechanism in vivo. Bone 2012 51 771 780
8. Riegel A., Maurer T., Prior B., Stegmaier S., Heppert V., Wagner C., Hänsch G. M., Human polymorphonuclear neutrophils express RANK and are activated by its ligand, RANKL. European Journal of Immunology 2012 42 4 975 981 2-s2.0-84860257862 10.1002/eji.201141786
9. Kim K. W., Kim H. R., Park J. Y., Park J. S., Oh H. J., Woo Y. J., Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis & Rheumatism 2012 64 1015 1023
10. Lam J., Takeshita S., Barker J. E., Kanagawa O., Ross F. P., Teitelbaum S. L., TNF- α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. Journal of Clinical Investigation 2000 106 12 1481 1488 2-s2.0-0034523328 (Pubitemid 32038586)
11. Onal M., Galli C., Fu Q., Xiong J., Weinstein R. S., Manolagas S. C., O'Brien C. A., The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice. Molecular Endocrinology 2012 26 2 341 348 2-s2.0-84856241068 10.1210/me.2011-1149
12. Kim S., Yamazaki M., Zella L. A., Shevde N. K., Pike J. W., Activation of receptor activator of NF- B ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers. Molecular and Cellular Biology 2006 26 17 6469 6486 2-s2.0-33747787316 10.1128/MCB.00353-06 (Pubitemid 44277887)
13. Nerenz R. D., Martowicz M. L., Pike J. W., An enhancer 20 kilobases upstream of the human receptor activator of nuclear factor- B ligand gene mediates dominant activation by 1,25-dihydroxyvitamin D3. Molecular Endocrinology 2008 22 5 1044 1056 2-s2.0-43049098242 10.1210/me.2007-0380 (Pubitemid 351629606)
14. Bogaczewicz J., Sysa-Jedrzejowska A., Arkuszewska C., Zabek J., Kontny E., McCauliffe D. P., Wozniacka A., Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 2012 21 5 477 484 2-s2.0-84859302332 10.1177/0961203311427549
15. Song G. G., Bae S. C., Lee Y. H., Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clinical Rheumatology 2012 31 1733 1739
16. Pelajo C. F., Lopez-Benitez J. M., Miller L. C., Vitamin D and autoimmune rheumatologic disorders. Autoimmunity Reviews 2010 9 7 507 510 2-s2.0-77951880110 10.1016/j.autrev.2010.02.011
17. Rossini M., Maddali Bongi S., la Montagna G., Minisola G., Malavolta N., Bernini L., Cacace E., Sinigaglia L., Di Munno O., Adami S., Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Research and Therapy 2010 12 6, article R216 2-s2.0-78649378417 10.1186/ar3195
18. Patel S., Farragher T., Berry J., Bunn D., Silman A., Symmons D., Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis and Rheumatism 2007 56 7 2143 2149 2-s2.0-34547421856 10.1002/art.22722 (Pubitemid 47173561)
19. Miyazawa K., Mori A., Okudaira H., Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 T antigen. Journal of Biochemistry 1998 124 6 1153 1162 2-s2.0-0032431998 (Pubitemid 29017304)
20. Hashizume M., Hayakawa N., Mihara M., IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- α and IL-17. Rheumatology 2008 47 11 1635 1640 2-s2.0-54449101331 10.1093/rheumatology/ken363
21. Kitazawa S., Kajimoto K., Kondo T., Kitazawa R., Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter. Journal of Cellular Biochemistry 2003 89 4 771 777 2-s2.0-0037636046 10.1002/jcb.10567 (Pubitemid 36759137)
22. Cantorna M. T., Hayes C. E., DeLuca H. F., 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. Journal of Nutrition 1998 128 1 68 72 2-s2.0-0031908097 (Pubitemid 28087178)
23. Larsson P., Mattsson L., Klareskog L., Johnsson C., A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clinical and Experimental Immunology 1998 114 2 277 283 2-s2.0-0031791746 10.1046/j.1365-2249.1998.00706.x (Pubitemid 28505730)
24. O'Brien C. A., Control of RANKL gene expression. Bone 2010 46 4 911 919 2-s2.0-77950537989 10.1016/j.bone.2009.08.050
25. McInnes I. B., Schett G., Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews Immunology 2007 7 6 429 442 2-s2.0-34249720998 10.1038/nri2094 (Pubitemid 46834849)
26. Schett G., Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Research and Therapy 2007 9 1, article 203 2-s2.0-34247589636 10.1186/ar2110 (Pubitemid 47262099)
27. Chan A., Filer A., Parsonage G., Kollnberger S., Gundle R., Buckley C. D., Bowness P., Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells. Arthritis and Rheumatism 2008 58 3 707 717 2-s2.0-40549117160 10.1002/art.23264 (Pubitemid 351364868)
28. Bartok B., Firestein G. S., Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunological Reviews 2010 233 1 233 255 2-s2.0-73249125200 10.1111/j.0105-2896.2009.00859.x
29. Li B., Baylink D. J., Deb C., Zannetti C., Rajaallah F., Xing W., 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS One 2013 8 3 e58808
30. Bucay N., Sarosi I., Dunstan C. R., Morony S., Tarpley J., Capparelli C., Scully S., Tan H. L., Xu W., Lacey D. L., Boyle W. J., Simonet W. S., Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes and Development 1998 12 9 1260 1268 2-s2.0-0032079445 (Pubitemid 28213402)
31. Peelen E., Knippenberg S., Muris A.-H., Thewissen M., Smolders J., Tervaert J. W. C., Hupperts R., Damoiseaux J., Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmunity Reviews 2011 10 12 733 743 2-s2.0-80053239608 10.1016/j.autrev.2011.05.002
32. Joshi S., Pantalena L.-C., Liu X. K., Gaffen S. L., Liu H., Rohowsky-Kochan C., Ichiyama K., Yoshimura A., Steinman L., Christakos S., Youssef S., 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Molecular and Cellular Biology 2011 31 17 3653 3669 2-s2.0-80052387833 10.1128/MCB.05020-11
33. Colin E. M., Asmawidjaja P. S., van Hamburg J. P., Mus A. M. C., van Driel M., Hazes J. M. W., Van Leeuwen J. P. T. M., Lubberts E., 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis and Rheumatism 2010 62 1 132 142 2-s2.0-74849095189 10.1002/art.25043